Last update:

Clinical pharmacology news

Experimental anesthetic may also blunt pain at nonsedating doses

Common intravenous anesthetics such as propofol and etomidate usually require additional pain medicines. Propofol and etomidate enhance GABA-A receptors, which act as brakes on nerve-cell activity, but generally do not relieve ...

Can psychedelics improve decision-making?

For the one-in-five Americans with a mental health condition, the options for treatment aren't too much different from what they were half a century ago. Most medicines for psychiatric disorders were first pioneered in the ...

Molecular glues: Unlocking new targets in cancer

The human genome encodes several hundred E3 ligases—the enzymes that decide which proteins a cell destroys. Drug developers have so far harnessed a small number of them. In a new review in Molecular Cell, researchers at Karolinska ...

Neurosteroid offers clues to brain changes linked to depression

UT Southwestern Medical Center researchers and colleagues, including two at UT Dallas, have found evidence that pregnenolone—a naturally occurring steroid hormone the body produces from cholesterol—may alter patterns of communication ...

Can a small DNA fix protect against Parkinson's disease?

In 2021, researchers at Oslo University Hospital discovered that by switching off a specific gene in the roundworm C. elegans, they could protect a particular type of nerve cell from age-related degeneration. These are the ...

How research paved the way for progress in a rare form of ALS

An experimental ALS drug that grew out of basic and clinical research at Columbia University's Vagelos College of Physicians and Surgeons may soon become available for patients with a rare and aggressive form of the disease.

RNA switch lets drugs control gene therapy protein production

Bioengineers at the University of California San Diego have developed a technology that allows drugs to control when cells produce therapeutic proteins, which could potentially make gene therapies safer and more adaptable ...

Precision RNA therapy offers hope for brain receptor disorders

Scientists at Johns Hopkins University School of Medicine and Academia Sinica in Taiwan have developed an experimental RNA-based treatment that prevents brain damage and improves learning, memory and social behavior in mice ...

China approves first oral GLP-1 weight-loss pill

China has approved its first orally administered GLP-1 weight-loss drug, permitting Eli Lilly to sell its orforglipron pill in a market where 630 million adults could be overweight or obese by 2050.

First atlas tracks proteins that cross the blood-brain barrier

Your brain is protected by the blood-brain barrier—a network of cells in the brain's blood vessels that serves as a border between the brain and the rest of your bloodstream. But it's not just a barrier; it's a sophisticated ...